This dual action reduces blood glucose spikes after eating and improves overall glucose stability throughout the day
Clinical trials have shown average weight loss of approximately 1521% of body weight with GLP-1 medications after approximately 70 weeks, depending on the medication and dose
In fact, the US Anti-Doping Authority says there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without any published conclusions
At Cymbiotika, our mission is to empower you with the tools you need to build a routine you can trust
Step 2: Be Consistent Antioxidant levels do not always reach their peak with a single dose
But until there's more data there, as far as looking at large populations and cancer incidence, like breast cancer, there is no increased incidence of breast cancer in patients taking GLP-1, and in fact, there seems to be a reduction in obesity-related cancers in those groups taking GLP-1